Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Babies of stressed mothers likely to get their teeth earlier

Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...

Customised immune cells used to fight brain cancer

Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...

Elevated blood protein levels predict mortality

Proteins that play key roles in the development of diseases such as cancer and inflammation may...

Content from other channels on our network

Could this tailored heart pump transform care for half of heart failure patients?

Monash University tailored heart pump — laboratory set-up

Minderoo Children's Comprehensive Cancer Centre, Randwick

Hospital fined $230K after aged care chair detachment

Helping to keep health care professionals hands-on

Four food safety tips for the silly season

Santa creates a spike in Australia's milk demand

Spicing up the festive season with Australian bushfood flavours

Kraft Heinz appoints Steve Cahillane as CEO

Irish drinks manufacturer takes its supply chain to the next level

Vaxxas secures TGA licence to manufacture vaccine patch technology

DroneShield nabs another European military contract

Daikin Australia opens new Sydney factory

AR3 to be first to process rare earths at ANSTO's new pilot facility

Defence Trailblazer funding manufacturing to help Defence and industry transition to clean energy